Live feed
Filing
SC 13G
SC 13G0000919574-17-006858·SEELOS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
APRICUS BIOSCIENCES INC
Security class unavailable · CUSIP: 03832V307
Event date: 2017-09-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-17-006858
- Form type
- SC 13G
- Filer
- SEELOS THERAPEUTICS, INC.
- CIK
- CIK 1017491
- Filed
- Sep 20, 2017
- Reporting period
- Sep 10, 2017
- Description
- Schedule 13G beneficial ownership